{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:20:21Z","timestamp":1787761221523,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The study aims to improve the success rate and the rapidity in creating artificial ascites before starting the treatment for subcapsular hepatocellular carcinomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Two hundred and forty-six consecutive hepatocellular carcinoma patients who required the instillation of artificial ascites for better visualization or prevention from organ injury were recruited between November 2011 and September 2017. Initially, 95 patients were using the Seldinger technique, while the remaining 151 patients were using the one-step method. The proportions of patients who had undergone surgery, transarterial chemoembolization, or radiofrequency ablation therapy before performing artificial ascites infusion were 11.6% (11\/95), 3% (3\/95), and 37% (35\/95) in the Seldinger group, and 15.9% (24\/151), 15.2% (23\/151), and 52.3% (79\/151), respectively, in the one-step group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The complete success rate, partial success rate, and failure rate in creating artificial ascites using the Seldinger technique and the one-step method were 76.8% (73\/95), 11.6% (11\/95), 11.6% (11\/95) and 88.1% (133\/151), 7.9% (12\/151), 4% (6\/151), respectively. The complete success rate was significantly higher in the one-step method group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05) than that of the Seldinger group. The mean time required from starting the procedure to successful intraperitoneal instillation of glucose water was 145.79 \u00b1 133.37 s in the one-step method, which was statistically shorter than that of 238.68 \u00b1 95.58 s in the Seldinger group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The one-step method has a higher success rate than the Seldinger method in creating artificial ascites and is faster, especially in treatment-experienced patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jmu.jmu_17_22","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T07:05:55Z","timestamp":1672124755000},"page":"287-290","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["One-Step Method in Creation of Artificial Ascites"],"prefix":"10.4103","volume":"30","author":[{"given":"Tienshin","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Li","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hung","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20240830","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"R2-9-20240830","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hep.21933","article-title":"Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?","volume":"47","author":"Livraghi","year":"2008","journal-title":"Hepatology"},{"key":"R3-9-20240830","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4329\/wjr.v2.i11.417","article-title":"Radiofrequency ablation of hepatocellular carcinoma: Current status","volume":"2","author":"Minami","year":"2010","journal-title":"World J Radiol"},{"key":"R4-9-20240830","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"R5-9-20240830","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4240\/wjgs.v2.i4.128","article-title":"Current status of radiofrequency ablation of hepatocellular carcinoma","volume":"2","author":"Rhim","year":"2010","journal-title":"World J Gastrointest Surg"},{"key":"R6-9-20240830","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1046\/j.1365-2168.2002.02168.x","article-title":"Complications of radiofrequency coagulation of liver tumours","volume":"89","author":"Mulier","year":"2002","journal-title":"Br J Surg"},{"key":"R7-9-20240830","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiol.2262012198","article-title":"Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study","volume":"226","author":"Livraghi","year":"2003","journal-title":"Radiology"},{"key":"R8-9-20240830","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2214\/ajr.183.3.1830583","article-title":"Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm","volume":"183","author":"Koda","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"R9-9-20240830","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2152\/jmi.54.48","article-title":"Influence of an artificial pleural effusion technique on cardio-pulmonary function and autonomic activity","volume":"54","author":"Fukuno","year":"2007","journal-title":"J Med Invest"},{"key":"R10-9-20240830","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2214\/AJR.07.2384","article-title":"Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience","volume":"190","author":"Rhim","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"R11-9-20240830","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1007\/s00330-009-1463-x","article-title":"Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: Safety and technical efficacy in 143 patients","volume":"19","author":"Song","year":"2009","journal-title":"Eur Radiol"},{"key":"R12-9-20240830","first-page":"279","article-title":"Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma","volume":"66","author":"Nishimura","year":"2012","journal-title":"Acta Med Okayama"},{"key":"R13-9-20240830","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1148\/radiol.2433060157","article-title":"Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: Frequency of diaphragmatic injury","volume":"243","author":"Head","year":"2007","journal-title":"Radiology"},{"key":"R14-9-20240830","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1148\/radiol.2223001805","article-title":"Minimizing diaphragmatic injury during radio-frequency ablation: Efficacy of subphrenic peritoneal saline injection in a porcine model","volume":"222","author":"Raman","year":"2002","journal-title":"Radiology"},{"key":"R15-9-20240830","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00261-008-9408-4","article-title":"Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: The value of artificial ascites","volume":"34","author":"Rhim","year":"2009","journal-title":"Abdom Imaging"},{"key":"R16-9-20240830","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5732\/cjc.010.10095","article-title":"Percutaneous ultrasound-guided thermal ablation for liver tumor with artificial pleural effusion or ascites","volume":"29","author":"Liu","year":"2010","journal-title":"Chin J Cancer"},{"key":"R17-9-20240830","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/02656736.2014.891765","article-title":"Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract","volume":"30","author":"Zhang","year":"2014","journal-title":"Int J Hyperthermia"}],"container-title":["Journal of Medical Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmu.jmu_17_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:27:40Z","timestamp":1787758060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmu.jmu_17_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jmu.jmu_17_22","relation":{},"ISSN":["0929-6441"],"issn-type":[{"value":"0929-6441","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}